Single-dose antibiotic for uncomplicated bladder infection in the ER
Treatments studied
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether giving one dose of amikacin in the emergency department is practical and safe for treating uncomplicated bladder infections. It also looks at how patients do after treatment over the next 3, 7, and 30 days.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman seen in the emergency department for a urinary problem
- You are 14 years old or older
- Your urine test shows nitrite-positive results, and your infection seems limited to the bladder (uncomplicated)
- You are not pregnant
- You have no signs of kidney infection or severe infection (sepsis)
- You can do a phone follow-up at 3, 7, and 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests LBP-EC01 to treat a bladder infection (UTI) caused by drug-resistant E. coli. It may help by targeting the specific bacteria that make UTIs harder to cure with common antibiotics.
This study helps doctors choose the best antibiotic for urinary tract infections (UTIs) by looking at urine culture results. You'll be treated as an outpatient (at home) and monitored to see if your antibiotic is working well.
This Phase 3 trial tests whether switching from short-term IV antibiotics to an oral antibiotic combo is safe and effective for ESBL urine infections. It may help you avoid staying on IV antibiotics as long, if your bacteria are the right match.
This study tests a new urine test (the UF-5000) to see if it can help doctors decide who really needs antibiotics for a bladder infection. The goal is to avoid giving antibiotics when they are not needed.
This trial tests whether a prediction model can help doctors choose the right antibiotic for women with a urinary tract infection (UTI) after an emergency room visit. It aims to improve treatment and reduce unnecessary antibiotics.
This trial tests whether fosfomycin works better than the usual treatment for children with urine infections caused by antibiotic-resistant germs. It may help by using an antibiotic choice that can still work when common oral options may fail.
Hear when a new Urinary Tract Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.